<DOC>
	<DOC>NCT01950637</DOC>
	<brief_summary>This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.</brief_summary>
	<brief_title>GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>PATIENTS WITH T2DM: Diagnosed with type 2 diabetes by a healthcare professional Currently being treated with insulin medication, excluding premix insulin treatment Age at least 40 years Diagnosed as having type 2 diabetes over the age of 40 HCPs: Primary care physician, diabetes specialist (diabetologist/endocrinologist) or diabetes specialist nurse/diabetes nurse educator Have a minimum of 2 years experience within current speciality See a minimum of 20 type 2 diabetes patients per month (40 for diabetes specialists), of which at least 10 per month must be on modern (analogue) inulins</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>